Marianne De Backer - Apr 3, 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Chief Executive Officer, Director
Signature: /s/ Sung Lee, Attorney-in-Fact
Stock symbol: VIR
Transactions as of: Apr 3, 2024
Transactions value $: -$690,365
Form type: 4
Date filed: 4/4/2024, 04:14 PM
Previous filing: Feb 26, 2024
Next filing: Jun 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Sale	-$690K	-73K	-9.71%	$9.46	678K	Apr 3, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.